Mid-Ohio Oncology/Hematology

Columbus, Ohio 43222

0 studies enrolling now · 8 studies all time

What they study most

Anemia, Epithelial Ovarian Cancer, Neoplasms, Hematologic, Non Small Cell Lung Carcinoma, Non-Small Cell Lung Cancer, Ovarian Neoplasms, Primary Peritoneal Carcinoma, Prostate Cancer, Refractory Diffuse Large B-Cell Lymphoma, Relapsed Diffuse Large B-Cell Lymphoma

Studies at this site

• A Study of LY2784544 in Participants With Myeloproliferative Neoplasms — Running, not enrolling
• Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Completed
• A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) — Stopped early
• Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer — Completed
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer — Completed
• Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy — Stopped early
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed